miRNAs as potential game-changers in melanoma: a comprehensive review

GM Abd-Allah, A Ismail, HA El-Mahdy… - … -Research and Practice, 2023 - Elsevier
Melanoma is the sixth most frequent malignancy. It represents 1.7% of all cancer cases
worldwide. Many risk factors are associated with melanoma including ultraviolet radiation …

Therapeutic peptides targeting intracellular molecules

R Zaman, EH Chowdhury - European Polymer Journal, 2024 - Elsevier
The increasing popularity of peptides and proteins targeted therapeutics is primarily
attributed to their inherent advantages, such as precise targeting and the reduction of side …

Optimization of process parameters for bevacizumab-loaded nanodispersion for lung cancer treatment

V Sethuraman, A Ramesh, K Janakiraman… - Journal of Dispersion …, 2024 - Taylor & Francis
Lung cancer is one of the most common and lethal types of cancer worldwide, needing
novel therapeutic approaches to enhance patient outcomes. Nanotechnology has emerged …

Patient reported medication-related problems, adherence and waste of oral anticancer medication over time

PMLA van den Bemt, MY Blijham… - European Journal of …, 2024 - ejhp.bmj.com
Objectives Patients on oral anticancer therapy regularly experience medication-related
problems (MRPs), potentially leading to non-adherence and medication waste. Most studies …